VTRS News and Press, Viatris Inc. From 12/02/25

2025-12-02 11:03:29 ET Viatris Inc. (VTRS) Piper Sandler 37th Annual Healthcare Conference December 2, 2025 8:30 AM EST... Read the full article on Seeking Alpha For further details see: Viatris Inc. (VTRS) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

NESS ZIONA, Israel, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing innovative long-acting depot injectable treatments, will participate in the 8 th Annual Evercore Annual Healthcare Confe...

2025-11-24 12:10:15 ET More on pharmaceuticals XPH: Small-Cap Pharma Turns Higher, At Long Last PPH: The Big Pharma ETF President Trump's 100% Tariff Threat: What It Means For Your Pharma Portfolio Short bets on S&P 500 Healthcare sector rises to 2.00% in...

2025-11-23 09:05:25 ET More on The Health Care Select Sector SPDR® Fund ETF XLV: Lower Interest Rates And A Positive Growth Outlook Will Pave The Way XLV: Market Overreaction Could Drive Double Digit Shareholder Yield XLV Vs. IHE: Will Pharmaceuticals Outperform...

Sol-Gel intends to pursue high-frequency BCC as an additional indication for its lead drug candidate SGT-610, which, if approved, could at least double the drug’s commercial potential In September 2025, Sol-Gel announced Health Canada approval of EPSOLAY Sol-Gel signed an additiona...

NORTHAMPTON, MA / ACCESS Newswire / November 18, 2025 / Viatris takes a multi-pronged approach to actively engage in addressing AMR, both by providing access through our portfolio of more than 90 antimicrobials and in partnership with others, including as a founding member and active board mem...

2025-11-18 08:38:47 ET Viatris Inc. (VTRS) Jefferies London Healthcare Conference 2025 November 18, 2025 6:30 AM EST... Read the full article on Seeking Alpha For further details see: Viatris Inc. (VTRS) Presents at Jefferies London Healthcare Conference 2025 Transcript

2025-11-16 19:07:31 ET This article is part of a series that provides an ongoing analysis of the changes made to Davis Selected Advisers’ 13F portfolio on a quarterly basis. It is based on their regulatory 13F Form filed on 11/12/2025. Please visit our Tracking Christopher ...

Viatris Recognized as One of the Fortune World's Best Workplaces™ in 2025 PR Newswire PITTSBURGH , Nov. 13, 2025 /PRNewswire/ --  Viatris Inc.  (Nasdaq: VTRS) today announced that it has been recognized as one of the Fortune World's Best Workplaces&...

2025-11-11 12:01:35 ET Viatris Inc. (VTRS) UBS Global Healthcare Conference 2025 November 11, 2025 8:45 AM EST... Read the full article on Seeking Alpha For further details see: Viatris Inc. (VTRS) Presents at UBS Global Healthcare Conference 2025 Transcript